当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析 - 现金流量表

博雅生物

(300294)

  

流通市值:72.01亿  总市值:72.01亿
流通股本:5.04亿   总股本:5.04亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,067,226,383.99694,890,612.44341,454,956.091,795,878,275.02
  收到其他与经营活动有关的现金14,306,588.9811,728,399.367,656,958.9860,308,940.02
  经营活动现金流入小计1,081,532,972.97706,619,011.8349,111,915.071,856,187,215.04
  购买商品、接受劳务支付的现金469,314,082.41338,852,571.08195,691,241.35768,172,040.87
  支付给职工以及为职工支付的现金293,723,895.38217,546,255.75135,041,340.57368,449,075.26
  支付的各项税费106,571,627.3893,246,055.8750,932,713.63183,180,958.57
  支付其他与经营活动有关的现金281,562,089.31193,282,402.5994,675,986.76475,222,452.76
  经营活动现金流出小计1,151,171,694.48842,927,285.29476,341,282.311,795,024,527.46
  经营活动产生的现金流量净额-69,638,721.51-136,308,273.49-127,229,367.2461,162,687.58
二、投资活动产生的现金流量:
  收回投资收到的现金5,100,816,819.242,761,091,453.312,261,091,453.314,975,020,107.17
  取得投资收益收到的现金59,134,534.0837,353,117.2524,765,666.0155,522,406.76
  处置固定资产、无形资产和其他长期资产收回的现金净额5,449,453.88396,375.39210,148.123,061,389.56
  处置子公司及其他营业单位收到的现金净额26,386,553.4826,386,553.48-193,790,119.76
  投资活动现金流入小计5,191,787,360.682,825,227,499.432,286,067,267.445,227,394,023.25
  购建固定资产、无形资产和其他长期资产支付的现金349,039,260.22282,930,449.39187,543,430.76535,308,549.07
  投资支付的现金4,817,516,013.482,727,538,463.862,281,000,0005,373,000,000
  投资活动现金流出小计5,166,555,273.73,010,468,913.252,468,543,430.765,908,308,549.07
  投资活动产生的现金流量净额25,232,086.98-185,241,413.82-182,476,163.32-680,914,525.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,000,000
  其中:子公司吸收少数股东投资收到的现金---1,000,000
  取得借款收到的现金11,230,00011,230,00011,230,00047,035,988.7
  筹资活动现金流入小计11,230,00011,230,00011,230,00048,035,988.7
  偿还债务支付的现金10,000---
  分配股利、利润或偿付利息支付的现金37,076,514.4337,116,263.41287,796.19156,396,539.61
  支付其他与筹资活动有关的现金10,799,006.567,041,136.084,137,061.6846,708,824.56
  筹资活动现金流出小计47,885,520.9944,157,399.494,424,857.87203,105,364.17
  筹资活动产生的现金流量净额-36,655,520.99-32,927,399.496,805,142.13-155,069,375.47
四、汇率变动对现金及现金等价物的影响-282,149.82-208,716.89-104,238.48-133,997.22
五、现金及现金等价物净增加额-81,344,305.34-354,685,803.69-303,004,626.91-774,955,210.93
  加:期初现金及现金等价物余额523,616,179.04523,616,179.04523,616,179.041,298,571,389.97
  期末现金及现金等价物余额442,271,873.7168,930,375.35220,611,552.13523,616,179.04
补充资料:
  净利润-50,884,883.53-112,638,772.02
  资产减值准备-4,877,063.36-316,529,570.79
  固定资产和投资性房地产折旧-42,523,343.15-96,960,872.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,523,343.15-96,910,547.58
    投资性房地产折旧---50,325.36
  无形资产摊销-17,616,505.75-49,621,357.38
  长期待摊费用摊销-3,832,647.81-13,040,303.6
  递延收益摊销---5,880,718.28
  处置固定资产、无形资产和其他长期资产的损失-394,883.47--5,095,324.42
  固定资产报废损失---1,343,862.03
  公允价值变动损失--10,444,438.13--59,977,597.95
  财务费用-1,247,412.3--14,541,893.43
  投资损失-34,436,670.69--23,806,314.16
  递延所得税--53,902,073.9--78,017,575.79
  其中:递延所得税资产减少--42,392,330.58--9,695,384.51
    递延所得税负债增加--11,509,743.32--68,322,191.28
  存货的减少--51,124,930.74--12,597,837.43
  经营性应收项目的减少--69,409,983.35--471,723,170.76
  经营性应付项目的增加--110,504,067.17-102,135,210.93
  不涉及现金收支的投资和筹资活动金额其他项目---11,095,417.78
  现金的期末余额-168,930,375.35-523,616,179.04
  减:现金的期初余额-523,616,179.04-1,298,571,389.97
  现金及现金等价物的净增加额--354,685,803.69--774,955,210.93
公告日期2026-10-302026-08-222026-04-252026-03-21
审计意见(境内)标准无保留意见
TOP↑